Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

64.55
Delayed Data
As of May 23
 +0.51 / +0.80%
Today’s Change
54.78
Today|||52-Week Range
66.80
+9.65%
Year-to-Date
Merck Presents Phase II Data on Chronic Cough Candidate
May 23 / Zacks.com - Paid Partner Content
Merck vs. Sanofi: Which Stock is a Better Pick Post Q1 Earnings?
May 22 / Zacks.com - Paid Partner Content
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna
May 23 / GuruFocus News - Paid Partner Content
Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose
May 22 / Zacks.com - Paid Partner Content
Merck Declares 47 Cent Quarterly Dividend
May 23 / TheStreet.com - Paid Partner Content
Amgen Evenity Approval Derailed on Cardiovascular Side Effect
May 22 / Zacks.com - Paid Partner Content
Merck & Co Faces Financial Hit From U.K. Regulator Over Drug Pricing
May 23 / TheStreet.com - Paid Partner Content
Howard Marks on the Truth About Investing
May 19 / GuruFocus News - Paid Partner Content
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
May 22 / Zacks.com - Paid Partner Content
Independent Advisor Alliance Buys Vanguard Total Stock Market, iShares Core U.S. ...
May 19 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close64.04
Today’s open64.00
Day’s range64.00 - 64.59
Volume5,734,591
Average volume (3 months)9,711,559
Market cap$175.2B
Dividend yield2.91%
Data as of 4:01pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+1.37%
Earnings growth (next 5 years)+4.70%
Revenue growth (last year)+1.86%
P/E ratio41.1
Price/Sales4.15
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.23-0.28%
PFEPfizer+0.02+0.06%
SNYSanofi-0.09-0.18%
GSKGlaxoSmithKline-0.34-0.79%
Data as of 05/23/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$0.88
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts